Feedback / Questions
astegolimab (RG 6149) - Amgen, Roche
Astegolimab: NME submission in US for COPD in 2025
(Roche)
-
Oct 23, 2024 -
Q3 2024 Results: Regulatory submission in EU for COPD in 2025
EMA filing • FDA filing
•
Chronic Obstructive Pulmonary Disease • Immunology
https://assets.roche.com/f/176343/x/31805a2578/irp231024.pdf
Oct 23, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious